Development of Intratumoral Drug Delivery Based Strategies for Antitumor Therapy

References

• chu X-Y, Huang W, Wang Y-L. Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin–chitosan nanoparticles loading paclitaxel–cholesterol complex. Int J Nanomed. 2019;14:689–705.
   PubMed Web of Science ®Google Scholar
• Wang C, Ye Y, Hochu GM, Sadeghifar H, Gu Z. Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody. Nano Lett. 2016;16:2334–2340.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N, Cai Z, Kwon YL, Lechtman E, Pignol JP, Reilly RM. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Breast Cancer Res Treat. 2013;137(1):81–91. doi:10.1007/s10549-012-2338-4
   PubMed Web of Science ®Google Scholar
• Al-Abd AM, Hong KY, Song SC, Kuh HJ. Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice. J Control Release. 2010;142(1):101–107. doi:10.1016/j.jconrel.2009.10.003
   PubMed Web of Science ®Google Scholar
• Ho-Chun S, Kun N, Park K-H. Intratumoral administration of rhenium-188-labeled pullulan acetate nanoparticles (PAN) in mice bearing CT-26 cancer cells for suppression of tumor growth. J Microbiol Biotechnol. 2006;16(10):1491–1498.
   Web of Science ®Google Scholar
• Brachi G, Ruiz-Ramírez J, Dogra P. Intratumoral injection of hydrogel-embedded nanoparticles enhances retention in glioblastoma. Nanoscale. 2020;12(46):23838–23850. doi:10.1039/D0NR05053A
   PubMed Web of Science ®Google Scholar
• Boone CE, Wang C, Lopez-Ramirez MA. Active Microneedle Administration of Plant Virus Nanoparticles for Cancer In Situ Vaccination Improves Immunotherapeutic Efficacy. ACS Appl. Nano Mater. 2023;3(8):8037–8051.
   Google Scholar
• Fan L, Duan M, Sun X. Injectable Liquid Metal- and Methotrexate-Loaded Microsphere for Cancer Chemophotothermal Synergistic Therapy. ACS Appl. Bio Mater. 2020;3(6):3553–3559. doi:10.1021/acsabm.0c00171
   PubMedGoogle Scholar
• Chattopadhyay N, Fonge H, Cai Z, et al. Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo. Mol Pharm. 2012;9(8):2168–2179.
   PubMed Web of Science ®Google Scholar
• Paszek MJ, Zahir N, Johnson KR, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8(3):241–254. doi:10.1016/j.ccr.2005.08.010
   PubMed Web of Science ®Google Scholar
• Tredan O, Galmarini CM, Patel K, Tannock IF, Natl J. Drug resistance and the solid tumor microenvironment. Cancer Inst. 2007;99(19):1441–1454. doi:10.1093/jnci/djm135
   Google Scholar
• Shido Y, Nishida Y, Suzuki Y, Kobayashi T, Ishiguro N. Targeted hyperthermia using magnetite cationic liposomes and an alternating magnetic field in a mouse osteosarcoma model. J Bone Joint Surg Br. 2010;92(4):580–585. doi:10.1302/0301-620X.92B4.22814
   PubMedGoogle Scholar
• Xu X, Huang Z, Huang Z, et al. Injectable, NIR/pH-Responsive Nanocomposite Hydrogel as Long-Acting Implant for Chemophotothermal Synergistic Cancer Therapy. ACS Appl. Mater. Interfaces. 2017;9(24):20361–20375. doi:10.1021/acsami.7b02307
   PubMed Web of Science ®Google Scholar
• Qu Y, Chu BY, Peng JR, et al. A biodegradable thermo-responsive hybrid hydrogel: therapeutic applications in preventing the post-operative recurrence of breast cancer. NPG Asia Materials. 2015;7(8):e207. doi:10.1038/am.2015.83
   Google Scholar
• Zhu Y, Yang Z, Dong Z, et al. CaCO3‑Assisted Preparation of pH‑Responsive Immune‑Modulating Nanoparticles for Augmented Chemo‑Immunotherapy. Nano-Micro Lett. 2021;13(1):29. doi:10.1007/s40820-020-00549-4
   Web of Science ®Google Scholar
• Jianbo G, Xue L, Hongdan Y, et al. The Anti-Melanoma Efficiency of the Intratumoral Injection of Cucurbitacin-Loaded Sustained-Release Carriers: a PLGA Particle. System. 2013;102:2550–2563.
   Google Scholar
• Sung Duk J, Lee J, Kyung Joo M, et al. PEG−PLA-Coated and Uncoated Radio-Luminescent CaWO4 Micro- and Nanoparticles for Concomitant Radiation and UV-A/RadioEnhancement Cancer Treatments. ACS Biomater Sci Eng. 2018;4:1445–1462. doi:10.1021/acsbiomaterials.8b00119
   PubMed Web of Science ®Google Scholar
• Yu L, Ding J. Injectable hydrogels as unique biomedical materials. Chem Soc Rev. 2008;37(8):1473–1481. doi:10.1039/b713009k
   PubMed Web of Science ®Google Scholar
• Mathew AP, Uthaman S, Cho KH, Cho CS, Park IK. Injectable hydrogels for delivering biotherapeutic molecules. Int JBiol Macromol. 2018;110:17–29. doi:10.1016/j.ijbiomac.2017.11.113
   PubMed Web of Science ®Google Scholar
• Ru Shin G, Eun Kim H, Kim JH, et al. Advances in Injectable In Situ-Forming Hydrogels for Intratumoral Treatment. Pharmaceutics. 2021;13(11):1953. doi:10.3390/pharmaceutics13111953
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhu X, Yandan J, et al. Near-Infrared-Triggered In-situ Hybrid Hydrogel System for Synergistic Cancer Therapy. J Mater Chem B. 2015;3(30):6310–6326. doi:10.1039/C5TB00904A
   PubMed Web of Science ®Google Scholar
• Wan J, Geng S, Zhao H, et al. Doxorubicin-induced co-assembling nanomedicines with temperature-sensitive acidic polymer and their in-situ-forming hydrogels for intratumoral administration. J Control Release. 2016;235:328–336. doi:10.1016/j.jconrel.2016.06.009
   PubMed Web of Science ®Google Scholar
• Raza F, Zhu Y, Chen L, et al. Paclitaxel-loaded pH Responsive Hydrogel Based on Self-assembly Peptides for Tumor Targeting. Biomater Sci. 2019;7(5):2023–2036. doi:10.1039/C9BM00139E
   PubMed Web of Science ®Google Scholar
• Sun X, Zhuang B, Zhang M, et al. Intratumorally Injected Photothermal Agent-Loaded Photodynamic Nanocarriers for Ablation of Orthotopic Melanoma and Breast Cancer. ACS Biomater Sci Eng. 2019;5(2):724–739. doi:10.1021/acsbiomaterials.8b01111
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56:1649–1659. doi:10.1016/j.addr.2004.02.014
   PubMed Web of Science ®Google Scholar
• Danhier F. To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? J Control Release. 2016;244(Pt A):108–121. doi:10.1016/j.jconrel.2016.11.015
   PubMed Web of Science ®Google Scholar
• Dawidczyk CM, Kim C, Park JH, et al. State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. J Control Release. 2014;187:133–144. doi:10.1016/j.jconrel.2014.05.036
   PubMed Web of Science ®Google Scholar
• Shen L, Zhang Z, Wang T, et al. Reversed lipid-based nanoparticles dispersed in oil for malignant tumor treatment via intratumoral injection. Drug Deliv. 2017;24(1):857–866. doi:10.1080/10717544.2017.1330373
   PubMed Web of Science ®Google Scholar
• Lee J, Phyu Hlaing S, Hasan N, et al. Tumor-Penetrable Nitric Oxide-Releasing Nanoparticles Potentiate Local Antimelanoma Therapy. ACS Appl Mater Interfaces. 2021;13(26):30383–30396. doi:10.1021/acsami.1c07407
   PubMed Web of Science ®Google Scholar
• Pirollo KF, Chang EH. Does a targeting ligand influence nanoparticle tumor localization or uptake? Trends Biotechnol. 2008;26:552–558. doi:10.1016/j.tibtech.2008.06.007
   PubMed Web of Science ®Google Scholar
• Huang X, Peng X, Wang Y, et al. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano. 2010;4(10):5887–5896. doi:10.1021/nn102055s
   PubMed Web of Science ®Google Scholar
• Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA. 2007;104(39):15549–15554. doi:10.1073/pnas.0707461104
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Bertrand N, Zope H, et al. Emerging understanding of the protein Corona at the nano-bio interfaces. Nano Today. 2016;11(6):817–832. doi:10.1016/j.nantod.2016.10.005
   Web of Science ®Google Scholar
• Chen FF, Wang GK, Griffin JI, et al. Complement proteins bind to nanoparticle protein Corona and undergo dynamic exchange in vivo. Nat Nanotechnol. 2017;12(4):387–393. doi:10.1038/nnano.2016.269
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Takamiya M, Jensen PB, et al. Differential Nanoparticle Sequestration by Macrophages and Scavenger Endothelial Cells Visualized in Vivo in Real-Time and at Ultrastructural Resolution. ACS Nano. 2020;14(2):1665–1681. doi:10.1021/acsnano.9b07233
   Web of Science ®Google Scholar
• Hansen AE, Petersen AL, Henriksen JR, et al. Positron emission tomography based elucidation of the enhanced permeability and retention effect in dogs with cancer using copper-64 liposomes. ACS Nano. 2015;9(7):6985–6995. doi:10.1021/acsnano.5b01324
   PubMed Web of Science ®Google Scholar
• Hou A, Quan G, Yang B, et al. Rational Design of Rapidly Separating Dissolving Microneedles for Precise Drug Delivery by Balancing the Mechanical Performance and Disintegration Rate. Adv Healthc Mater. 2019;8(21):e1900898. doi:10.1002/adhm.201900898
   PubMed Web of Science ®Google Scholar
• Biyuan W, Jintao F, Zhou Y, et al. Tailored core‒shell dual metaleorganic frameworks as a versatile nanomotor for effective synergistic antitumor therapy. Acta Pharm Sin B. 2020;10(11):2198–2211. doi:10.1016/j.apsb.2020.07.025
   Web of Science ®Google Scholar
• Qin W, Quan G, Sun Y, et al. Dissolving Microneedles with Spatiotemporally controlled pulsatile release Nanosystem for Synergistic Chemo-photothermal Therapy of Melanoma. Theranostics. 2020;10(18):8179–8196. doi:10.7150/thno.44194
   PubMed Web of Science ®Google Scholar
• Boone CE, Wang C, Angel Lopez-Ramirez M, et al. Active Microneedle Administration of Plant Virus Nanoparticles for Cancer In Situ Vaccination Improves Immunotherapeutic Efficacy. ACS Appl Nano Mater. 2020;3(8):8037–8051. doi:10.1021/acsanm.0c01506
   Web of Science ®Google Scholar
• Tian L, Gao J, Yang Z, Huang G. Tamibarotene-loaded PLGA microspheres for intratumoral injection administration: preparation and evaluation. AAPS Pharm Sci Tech. 2018;19(1):275–283. doi:10.1208/s12249-017-0827-9
   PubMed Web of Science ®Google Scholar
• Doty AC, Weinstein DG, Hirota K. Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres. J Control Release. 2017;256:19–25. doi:10.1016/j.jconrel.2017.03.031
   PubMed Web of Science ®Google Scholar
• Doty AC, Zhang Y, Weinstein DG. Mechanistic analysis of triamcinolone acetonide release from PLGA microspheres as a function of varying in vitro release conditions. Eur J Pharm Biopharm. 2017;113:24–33. doi:10.1016/j.ejpb.2016.11.008
   PubMed Web of Science ®Google Scholar
• Guo WJ, Quan P, Fang L, Cun DM, Yang MS. Sustained release donepezil loaded PLGA microspheres for injection: preparation, in vitro and in vivo study. Asian J Pharm Sci. 2015;10(5):405–414. doi:10.1016/j.ajps.2015.06.001
   Web of Science ®Google Scholar
• Benny O, Kim SK, Gvili K. In vivo fate and therapeutic efcacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model. FASEB J. 2008;22(2):488–499. doi:10.1096/fj.07-8801com
   PubMed Web of Science ®Google Scholar
• Guoli N, Yang G, Yang H, et al. Uniformly sized hollow microspheres loaded with polydopamine nanoparticles and doxorubicin for local chemo-photothermal combination therapy. Chem Eng J. 2020;379:122317. doi:10.1016/j.cej.2019.122317
   Web of Science ®Google Scholar
• Zhou YL, Wang HT, Du QG. Effect of initiation site location on morphology of polymer microspheres via pickering polymerization. J Polym Sci. 2012;50:3537–3545. doi:10.1002/pola.26138
   Web of Science ®Google Scholar
• Wang SY, Shi XD, Gan ZH, Wang F. Preparation of PLGA Microspheres with Different Porous Morphologies Chin. J Polym Sci. 2015;33(1):128–136.
   Google Scholar
• Zhang Z, Wang X, Binbin L, et al. Paclitaxel-loaded PLGA microspheres with a novel morphology to facilitate drug delivery and antitumor efficiency. RSC Adv. 2018;8(6):3274–3285. doi:10.1039/C7RA12683B
   PubMed Web of Science ®Google Scholar
• Zou Y, Song Y, Yang WJ, et al. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice. J Control Release. 2014;193:154–161. doi:10.1016/j.jconrel.2014.05.016
   PubMed Web of Science ®Google Scholar
• Omid C, Jianjun C, Benjamin AT, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A. 2006;103(16):6315–6320. doi:10.1073/pnas.0601755103
   Web of Science ®Google Scholar
• Yang L, Song X, Gong T, et al. Enhanced anti-tumor and anti-metastasis efficacy against breast cancer with an intratumoral injectable phospholipids-based phase separation gel co-loaded with 5-fluotouracil and magnesium oxide by neutralizing acidic microenvironment. Int J Pharm. 2018;547(1–2):181–189. doi:10.1016/j.ijpharm.2018.05.072
   Google Scholar
• Lun Wong H, Mike Rauth A, Bendayan R, Wu XY. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model. Eur J Pharm Biopharm. 2007;65(3):300–308. doi:10.1016/j.ejpb.2006.10.022
   Web of Science ®Google Scholar
• Kyoo Seong S, Man Ryu J, Hyuk Shin D, et al. Biodistribution and excretion of radioactivity after the administration of 166 Ho-chitosan complex (DW-166HC) into the prostate of rat. Eur J Nucl Med Mol Imaging. 2005;32(8):910–917. doi:10.1007/s00259-005-1792-1
   Web of Science ®Google Scholar
• Geng F, Song K, Xing JZ, et al. Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer. Nanotechnology. 2011;22(28):285101. doi:10.1088/0957-4484/22/28/285101
   PubMed Web of Science ®Google Scholar
• Yoon HY, Koo H, Choi KY, et al. Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials. 2012;3315:3980–3989. doi:10.1016/j.biomaterials.2012.02.016
   Google Scholar
• Nakajo M, Kobayashi H, Shimabukuro K, et al. Biodistribution and in vivo kinetics of iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer. J Nucl Med. 1988;29(6):1066–1077.
   Web of Science ®Google Scholar
• Suzuki YS, Momose Y, Higashi N, et al. Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice. J Nucl Med. 1998;39(12):2161–2166.
   Web of Science ®Google Scholar
• Li D, Hu D, Xu H, et al. Progress and perspective of microneedle system for anti-cancer drug delivery. Biomaterials. 2021;264:120410. doi:10.1016/j.biomaterials.2020.120410
   PubMed Web of Science ®Google Scholar
• Marabelle A, Kohrt H, Caux C, et al. Intratumoral immunization: a new paradigm for cancer therapy. Clin Cancer Res. 2014;20(7):1747–1756. doi:10.1158/1078-0432.CCR-13-2116
   PubMed Web of Science ®Google Scholar
• Corrales L, Glickman LH, McWhirter SM, et al. Direct activation of sting in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 2015;11(7):1018–1030. doi:10.1016/j.celrep.2015.04.031
   PubMed Web of Science ®Google Scholar
• Macedo N, Miller DM, Haq R, et al. Clinical landscape of oncolytic virus research in 2020. J Immunother Cancer. 2020;8(2):e001486. doi:10.1136/jitc-2020-001486
   PubMed Web of Science ®Google Scholar
• Lee KL, Murray AA, Le DHT, et al. Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response. Nano Lett. 2017;17(7):4019–4028. doi:10.1021/acs.nanolett.7b00107
   PubMed Web of Science ®Google Scholar
• Jiang X, Wang J, Zheng X, et al. Intratumoral administration of STINGactivating nanovaccine enhances T cell immunotherapy. J Immunother Cancer. 2022;10(5):e003960. doi:10.1136/jitc-2021-003960
   PubMed Web of Science ®Google Scholar
• Mohsen MO, Heath M, Kramer MF, et al. In situ delivery of nanoparticles formulated with micron-sized crystals protects from murine melanoma. J Immunother Cancer. 2022;10(9):e004643. doi:10.1136/jitc-2022-004643
   Web of Science ®Google Scholar
• Liu JQ, Zhu J, Hu A. Is AAV-delivered IL-27 a potential immunotherapeutic for cancer? Am J Cancer Res. 2020;10(11):3565–3574.
   Web of Science ®Google Scholar
• Liu J-Q, Zhang C, Zhang X, et al. Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy. J Control Release. 2022;345:306–313. doi:10.1016/j.jconrel.2022.03.021
   PubMed Web of Science ®Google Scholar
• Link BK, Ballas ZK, Weisdorf D, et al. Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma. J Immunother. 2006;29(5):558–568. doi:10.1097/01.cji.0000211304.60126.8f
   PubMed Web of Science ®Google Scholar
• Maurer T. Immunostimulatory CpG-DNA and PSApeptide vaccination elicits profound cytotoxic T cell responses. Urol Oncol. 2013;31(7):1395–1401. doi:10.1016/j.urolonc.2011.09.002
   Web of Science ®Google Scholar
• Zhang X, Fengbo W, Men K, et al. Modified Fe3O4 Magnetic Nanoparticle Delivery of CpG Inhibits Tumor Growth and Spontaneous Pulmonary Metastases to Enhance Immunotherapy. Nanoscale Res Lett. 2018;13(1):240. doi:10.1186/s11671-018-2661-8
   PubMedGoogle Scholar
• Celli JP, Spring BQ, Rizvi I, et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev. 2010;110(5):2795–2838. doi:10.1021/cr900300p
   PubMed Web of Science ®Google Scholar
• Chen Q, Wen J, Li H, Xu Y, Liu F, Sun S. Recent advances in different modal imaging-guided photothermal therapy. Biomaterials. 2016;106:144–166. doi:10.1016/j.biomaterials.2016.08.022
   PubMed Web of Science ®Google Scholar
• Robertson CA, Hawkins Evans D, Abrahamse H. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B. 2009;96(1):1–8. doi:10.1016/j.jphotobiol.2009.04.001
   PubMed Web of Science ®Google Scholar
• Dickerson EB, Dreaden EC, Huang X, et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 2008;269(1):57–66. doi:10.1016/j.canlet.2008.04.026
   PubMed Web of Science ®Google Scholar
• Niidome T, Yamagata M, Okamoto Y, et al. PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release. 2006;114(3):343–347. doi:10.1016/j.jconrel.2006.06.017
   PubMed Web of Science ®Google Scholar
• De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29(12):1912–1919. doi:10.1016/j.biomaterials.2007.12.037
   PubMed Web of Science ®Google Scholar
• Green HN, Crockett SD, Martyshkin DV, et al. A histological evaluation and in vivo assessment of intratumoral near infrared photothermal nanotherapy-induced tumor regression. Int J Nanomed. 2014;9:5093–5102. doi:10.2147/IJN.S60648
   PubMed Web of Science ®Google Scholar
• Wang C, Tao H, Cheng L, Liu Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials. 2011;32(26):6145–6154. doi:10.1016/j.biomaterials.2011.05.007
   PubMed Web of Science ®Google Scholar
• Zhue D, Zhengb Z, Luo G, et al. Single injection and multiple treatments: an injectable nanozyme hydrogel as AIEgen reservoir and release controller for efficient tumor therapy. Nano Today. 2021;37:101091. doi:10.1016/j.nantod.2021.101091
   Web of Science ®Google Scholar
• Von Maltzahn G, Park JH, Agrawal A, et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res. 2009;69(9):3892–3900. doi:10.1158/0008-5472.CAN-08-4242
   PubMed Web of Science ®Google Scholar
• Choi J, Kim HY, Ju EJ, et al. Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. Biomaterials. 2012;33(16):4195–4203. doi:10.1016/j.biomaterials.2012.02.022
   PubMed Web of Science ®Google Scholar
• Mooney R, Roma L, Zhao D, et al. Neural stem cell-mediated delivery of gold nanorods improves photothermal therapy. ACS Nano. 2014;8(12):12450–12460. doi:10.1021/nn505147w
   PubMed Web of Science ®Google Scholar
• Zhibin L, Huang H, Tang S, et al. Small Gold Nanorods Laden Macrophages for Enhanced Tumor Coverage in Photothermal Therapy. Biomaterials. 2016;74:144–154. doi:10.1016/j.biomaterials.2015.09.038
   Web of Science ®Google Scholar
• Sun J, Wen X, Liping L, et al. Ultrasmall Endogenous Biopolymer Nanoparticles for Magnetic Resonance /Photoacoustic Dual-Modal Imaging-Guided Photothermal Therapy. Nanoscale. 2018;10(22):10584–10595. doi:10.1039/C8NR01215F
   Web of Science ®Google Scholar
• Kobayashi T. Cancer hyperthermia using magnetic nanoparticles. Biotechnol J. 2011;6(11):1342–1347. doi:10.1002/biot.201100045
   PubMed Web of Science ®Google Scholar
• Johannsen M, Thiesen B, Jordan A, et al. Magnetic Fluid Hyperthermia (MFH) Reduces Prostate Cancer Growth in the Orthotopic Dunning R3327 Rat Model. Prostate. 2005;64(3):283–292. doi:10.1002/pros.20213
   PubMed Web of Science ®Google Scholar
• Kettering M, Richter H, Wiekhorst F, et al. Minimal-invasive magnetic heating of tumors does not alter intra-tumoral nanoparticle accumulation, allowing for repeated therapy sessions: an in vivo study in mice. Nanotechnology. 2011;22(50):505102. doi:10.1088/0957-4484/22/50/505102
   PubMed Web of Science ®Google Scholar
• Chauhan A, Midha S, Kumar R, et al. Rapid tumor inhibition via magnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles. Biomater Sci. 2021;9(8):2972–2990. doi:10.1039/D0BM01705A
   PubMed Web of Science ®Google Scholar
• Ito A, Tanaka K, Kondo K, et al. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci. 2003;94(3):308–313. doi:10.1111/j.1349-7006.2003.tb01438.x
   PubMed Web of Science ®Google Scholar
• Tanaka K, Ito A, Kobayashi T, et al. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. Int, J, Cancer. 2005;116(4):624–633. doi:10.1002/ijc.21061
   PubMed Web of Science ®Google Scholar
• Hilger I, Hiergeist R, Hergt R, et al. Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study. Invest Radiol. 2002;37(10):580–586. doi:10.1097/00004424-200210000-00008
   PubMed Web of Science ®Google Scholar
• Johannsen M, Gneveckow U, Eckelt L, et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperther. 2005;21(7):637–647. doi:10.1080/02656730500158360
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Yuba E, Harada A, Kono K. Preparation of photothermal-chemotherapy nanohybrids by complexation of gold nanorods with polyamidoamine dendrimers having poly(ethylene glycol) and hydrophobic chains. J Mater Chem B. 2020;8(14):2826–2833. doi:10.1039/C9TB02163A
   Web of Science ®Google Scholar
• Kossatz S, Grandke J, Couleaud P, et al. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Res. 2015;17(1):66. doi:10.1186/s13058-015-0576-1
   PubMed Web of Science ®Google Scholar
• Wang D, Wan Z, Yang Q, et al. Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes. Drug Deliv. 2022;29(1):702–713. doi:10.1080/10717544.2022.2044937
   PubMed Web of Science ®Google Scholar
• Tingting L, Zhang M, Wang J, et al. Thermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective Chemoradiotherapy. AAPS J. 2016;18(1):146–155. doi:10.1208/s12248-015-9828-3
   Web of Science ®Google Scholar
• Wang Z, Liu B, Jingyao T, et al. PLGA Nanoparticles Loaded with Sorafenib Combined with Thermosensitive Hydrogel System and Microwave Hyperthermia for Multiple Sensitized Radiotherapy. Pharmaceutics. 2023;15(2):487. doi:10.3390/pharmaceutics15020487
   Web of Science ®Google Scholar
• Zeng W, Liu C, Wang S, Wang Z, Huang Q. SnFe2O4 Nanozyme Based TME Improvement System for Anti-Cancer Combination Thermoradiotherapy. Front Oncol. 2021;11:768829. doi:10.3389/fonc.2021.768829
   Web of Science ®Google Scholar
• Gogoi M, Jaiswal MK, Dev Sarma H, Bahadur D, Banerjee R. Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy. Integr Biol (Camb). 2017;9(6):555–565. doi:10.1039/C6IB00234J
   PubMed Web of Science ®Google Scholar
• Manfred J, Burghard T, Uwe G, et al. Thermotherapy Using Magnetic Nanoparticles Combined With External Radiation in an Orthotopic Rat Model of Prostate Cancer. Prostate. 2006;66(1):97–104. doi:10.1002/pros.20324
   Web of Science ®Google Scholar
• Janic B, Brown SL, Neff R, et al. Gold Nanoparticle (AuNP) as a Therapeutic Enhancer for Radio – and Immunotherapy Therapy Combination in Triple Negative Breast Cancer. Int J Radiat Oncol Biol Phys. 2022;114(3):e522–e522. doi:10.1016/j.ijrobp.2022.07.2114
   Web of Science ®Google Scholar
• Banstola A, Pandit M, Duwa R, et al. Reactive oxygen species-responsive dual-targeted nanosystem promoted immunogenic cell death against breast cancer. Bioeng Transl Med. 2022;8(5):e10379. doi:10.1002/btm2.10379
   Web of Science ®Google Scholar
• Gorgizadeh M, Behzadpour N, Salehi F, et al. A MnFe2O4/C nanocomposite as a novel theranostic agent in MRI, sonodynamic therapy and photothermal therapy of a melanoma cancer model. Journal of Alloys and Compounds. 2020;816.
   Web of Science ®Google Scholar
• Yata T, Takahashi Y, Tan M, et al. DNA nanotechnology-based composite-type gold nanoparticle-immunostimulatory DNA hydrogel for tumor photothermal immunotherapy. Biomaterials. 2017;146:136–145. doi:10.1016/j.biomaterials.2017.09.014
   Web of Science ®Google Scholar
• Yang Z, Tao D, Zhong W, et al. Perfluorocarbon loaded fluorinated covalent organic polymers with effective sonosensitization and tumor hypoxia relief enable synergistic sonodynamic-immunotherapy. Biomaterials. 2022;280:121250. doi:10.1016/j.biomaterials.2021.121250
   Web of Science ®Google Scholar
• Xia ZJ, Chang JH, Zhang L, et al. Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or esophagus. Chin J Cancer. 2004;23(12):1666e70.
   Google Scholar
• Zhu HL, Xie P. The safety and short-term clinical observation of endoscopic intratumoral injection of recombinant human p53 adenovirus on advanced esophageal cancer. Pract J Clin Med. 2012;9(4):79e80.
   Google Scholar
• Jenks N, Myers R, Greiner SM, et al. Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-b in rodents and nonhuman primates. Hum Gene Ther. 2010;21:451e62. doi:10.1089/hum.2009.111
   Web of Science ®Google Scholar
• Mazzolini G, Alfaro C, Sangro B, et al. Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas. J Clin Oncol. 2005;23(5):999e1010. doi:10.1200/JCO.2005.00.463
   Web of Science ®Google Scholar
• Mehta HJ, Begnaud A, Penley AM, et al. Treatment of isolated mediastinal and hilar recurrence of lung cancer with bronchoscopic endobronchial ultrasound guided intratumoral injection of chemotherapy with cisplatin. Lung Cancer. 2015;90(3):542–547. doi:10.1016/j.lungcan.2015.10.009
   Web of Science ®Google Scholar
• Mehta HJ, Jantz MA. Endobronchial ultrasound-guided intratumoral injection of cisplatin for the treatment of isolated mediastinal recurrence of lung cancer. J Vis Exp. 2017;120:54855.
   Google Scholar
• Andtbacka RH, Kaufman HL, Collichio F, et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol. 2015;33(25):2780–2788. doi:10.1200/JCO.2014.58.3377
   PubMed Web of Science ®Google Scholar
• Kepp O, Marabelle A, Zitvogel L. Guido KroemerOncolysis without viruses - inducing systemic anticancer immune responses with local therapies. Nat Rev Clin Oncol. 2020;17(1):49–64. doi:10.1038/s41571-019-0272-7
   Web of Science ®Google Scholar
• Qutachi O, Wright EJ, Bray G, et al. Improved delivery of PLGA microparticles and microparticle-cell scaffolds in clinical needle gauges using modified viscosity formulations. Int J Pharm. 2018;546(1–2):272–278. doi:10.1016/j.ijpharm.2018.05.025
   Google Scholar
• Nasiri R, Almaki JH, Idris A, et al. Targeted delivery of bromelain using dual mode nanoparticles: synthesis, physicochemical characterization, in vitro and in vivo evaluation. RSC Adv. 2017;7(64):40074–40094. doi:10.1039/C7RA06389J
   Web of Science ®Google Scholar
• Meiling Y, Zhang C, Tang Z, Tang X, Hui X. Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity. Cancer Lett. 2019;442:396–408. doi:10.1016/j.canlet.2018.11.011
   Web of Science ®Google Scholar
• Melero I, Castanon E, Alvarez M, Champiat S, Marabelle A. Intratumoural administration and tumour tissue targeting of cancer immunotherapies. Nat Rev Clin Oncol. 2021;18(9):558–576. doi:10.1038/s41571-021-00507-y
   PubMed Web of Science ®Google Scholar